Dr Hilmar Sigurdsson
Dr Lisa Alcock
Dr Michael Firbank
Ross Wilson
Philip Brown
et al. | Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait | 2024 |
|
Professor Nicola Pavese
| Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism | 2024 |
|
Dr Jacopo Pasquini
Dr Michael Firbank
Victoria Foster
Debra Galley
Emeritus Professor David Brooks
et al. | Hypothalamic involvement in multiple system atrophy: A structural MRI study | 2024 |
|
Emeritus Professor David Brooks
Professor Nicola Pavese
| Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder | 2024 |
|
Professor David Brooks
Professor Nicola Pavese
| Progression of brain cholinergic dysfunction in patients with isolated REM sleep behaviour disorder | 2024 |
|
Professor Nicola Pavese
| Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study | 2023 |
|
Charlotte Stewart
Dr David Ledingham
Victoria Foster
Dr Kirstie Anderson
Dr Sahana Sathyanarayana
et al. | Corrigendum: The longitudinal progression of autonomic dysfunction in Parkinson's disease: a 7-year study (Front. Neurol., (2023), 14, 1155669, 10.3389/fneur.2023.1155669) | 2023 |
|
Professor Nicola Pavese
| DBS in tremor with dystonia: VIM, GPi or both? A review of the literature and considerations from a single-center experience | 2023 |
|
Dr Alessandro Galgani
Professor Nicola Pavese
| Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia | 2023 |
|
Professor Nicola Pavese
| Prevalence and severity of freezing of gait in a Danish cohort of people with Parkinsonʼs disease | 2023 |
|
Professor Nicola Pavese
Professor David Brooks
| Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB-J and [18F]FDG PET Study | 2023 |
|
Professor Nicola Pavese
Professor David Brooks
| Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB-J and [18F]FDG PET Study | 2023 |
|
Charlotte Stewart
Dr David Ledingham
Victoria Foster
Dr Kirstie Anderson
Dr Sahana Sathyanarayana
et al. | The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study | 2023 |
|
Professor Nicola Pavese
| Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x) | 2022 |
|
Professor Nicola Pavese
| Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum | 2022 |
|
Dr Jacopo Pasquini
Dr Michael Firbank
Professor Nicola Pavese
| Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review | 2022 |
|
Dr Hilmar Sigurdsson
Professor Alison Yarnall
Dr Brook Galna
Dr Susan Lord
Dr Lisa Alcock
et al. | Gait-related metabolic covariance networks at rest in Parkinson’s disease | 2022 |
|
Professor Nicola Pavese
| Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson’s disease | 2022 |
|
Professor Nicola Pavese
| Interventions to improve gait in Parkinson’s disease: a systematic review of randomized controlled trials and network meta-analysis | 2022 |
|
Professor Nicola Pavese
| Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects | 2022 |
|
Dr Alessandro Galgani
Professor Nicola Pavese
| Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach | 2022 |
|
Dr Zheyu Xu
Dr Kirstie Anderson
Professor Nicola Pavese
| Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease | 2022 |
|
Professor Nicola Pavese
Professor David Brooks
| Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study | 2022 |
|
Professor David Burn
Professor Nicola Pavese
| Neurofilament light levels predict clinical progression and death in multiple system atrophy | 2022 |
|
Laura Parkes
Professor Nicola Pavese
Professor David Burn
| Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis | 2022 |
|
Professor Nicola Pavese
| Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease | 2022 |
|
Professor Nicola Pavese
| Private Facial Prediagnosis as an Edge Service for Parkinson's DBS Treatment Valuation | 2022 |
|
Professor Nicola Pavese
| Robust Brain Age Estimation based on sMRI via Nonlinear Age-Adaptive Ensemble Learning | 2022 |
|
Professor Nicola Pavese
| Studying cognitive function in patients with a long-standing diagnosis of SWEDD | 2022 |
|
Professor Nicola Pavese
| Trial of Deferiprone in Parkinson's Disease | 2022 |
|
Professor Nicola Pavese
| Trial of Prasinezumab in Early-Stage Parkinson's Disease | 2022 |
|
Professor Nicola Pavese
| Atypical Parkinsonian Syndromes and Subtypes of Parkinson's Disease. Will a Single Neuroimaging Modality Ever Be Enough? | 2021 |
|
Professor Nicola Pavese
Professor David Brooks
| Brain microglial activation increased in glucocerebrosidase (GBA1) mutation carriers | 2021 |
|
Professor David Brooks
Professor Nicola Pavese
| Impaired cerebral microcirculation in isolated rapid eye movement sleep behaviour disorder | 2021 |
|
Professor David Brooks
Professor Nicola Pavese
| Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: a [11C]-PHNO PET study | 2021 |
|
Professor David Brooks
Professor Nicola Pavese
| Monocyte markers correlate with immune and neuronal brain changes in REM Sleep Behaviour Disorder | 2021 |
|
Professor Nicola Pavese
Professor David Brooks
| Preserved noradrenergic function in Parkinson´s disease patients with rest tremor | 2021 |
|
Dr Kirstie Anderson
Dr Rachael Lawson
Professor David Brooks
Professor Nicola Pavese
| Progression of sleep disturbances in Parkinson’s Disease. A 5-year longitudinal study. | 2021 |
|
Dr Jacopo Pasquini
Professor Nicola Pavese
| Striatal dopaminergic denervation and hypomimia in Parkinson's disease | 2021 |
|
Dr Jacopo Pasquini
Professor David Brooks
Professor Nicola Pavese
| The Cholinergic Brain in Parkinson's Disease | 2021 |
|
Professor Nicola Pavese
Professor David Brooks
| Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder – a PET study | 2020 |
|
Professor Nicola Pavese
Professor David Brooks
| Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study | 2020 |
|
Professor Nicola Pavese
Professor David Brooks
| Brain-first vs. Body-first Parkinson’s disease: a multi-modal imaging case-control study | 2020 |
|
Professor David Brooks
Professor Nicola Pavese
| Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder | 2020 |
|
Dr Gabriele Bellini
Dr Laura Best
Professor Nicola Pavese
| Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease | 2020 |
|
Professor David Burn
Professor Nicola Pavese
| Diagnosis across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome | 2020 |
|
Professor Nicola Pavese
| Dopamine Transporter, Age, and Motor Complications in Parkinson's Disease: A Clinical and Single-Photon Emission Computed Tomography Study | 2020 |
|
Professor David Brooks
Professor Nicola Pavese
| Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers | 2020 |
|
Dr Uma Nath
Professor Nicola Pavese
| The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation | 2020 |
|
Dr Rory Durcan
Dr Lou Wiblin
Professor Lynn Rochester
Professor David Brooks
Professor David Burn
et al. | Clinical implications of early caudate dysfunction in Parkinson’s disease | 2019 |
|
Professor Nicola Pavese
| Is neuromelanin the imaging biomarker for the early diagnosis of Parkinson's disease that we were looking for? | 2019 |
|
Professor Nicola Pavese
| Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System | 2019 |
|
Dr Laura Best
Professor Nicola Pavese
| New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease | 2019 |
|
Dr Laura Best
Professor Nicola Pavese
| PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases | 2019 |
|
Dr Rory Durcan
Dr Lou Wiblin
Dr Rachael Lawson
Dr Tien Kheng Khoo
Professor Alison Yarnall
et al. | Prevalence and duration of non‐motor symptoms in prodromal Parkinson's disease | 2019 |
|
Professor David Brooks
Professor Nicola Pavese
| Progressive loss of raphe nuclei serotonin transporter in early Parkinson’s disease: a longitudinal 123I-FP-CIT SPECT study | 2019 |
|
Professor Nicola Pavese
Professor Johannes Attems
| Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration | 2019 |
|
Professor Nicola Pavese
| The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy | 2019 |
|
Professor Nicola Pavese
| A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease | 2018 |
|
Professor David Brooks
Professor Nicola Pavese
| Extrastriatal monoaminergic dysfunction and enhanced microglial activation in idiopathic rapid eye movement sleep behaviour disorder | 2018 |
|
Professor Nicola Pavese
| Imaging Markers of Progression in Parkinson's Disease | 2018 |
|
Professor Nicola Pavese
Professor David Brooks
| In vivo staging of pathology in REM Sleep Behaviour Disorder – a multi-modality imaging case-control study | 2018 |
|
Professor Nicola Pavese
| Nigrosome imaging and neuromelanin sensitive MRI in diagnostic evaluation of parkinsonism | 2018 |
|
Professor Nicola Pavese
| Outcome of cell suspension allografts in a patient with Huntington’s disease | 2018 |
|
Professor Nicola Pavese
| Pallidal dopaminergic denervation and rest tremor in early Parkinson’s disease: PPMI cohort analysis | 2018 |
|
Professor Nicola Pavese
| Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review | 2018 |
|
Dr Zheyu Xu
Professor Nicola Pavese
| PET Molecular Imaging in Atypical Parkinsonism | 2018 |
|
Johann Pasquier
Professor David Brooks
Professor Nicola Pavese
| Progression of tremor in early stages of Parkinson’s disease: a clinical and neuroimaging study | 2018 |
|
Professor David Brooks
Professor Nicola Pavese
| Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A case-control study | 2017 |
|
Professor Nicola Pavese
| Automated assessment of symptom severity changes during deep brain stimulation (DBS) therapy for Parkinson's disease | 2017 |
|
Professor Nicola Pavese
| Biased numerical cognition impairs economic decision-making in Parkinson's disease | 2017 |
|
Professor Nicola Pavese
Professor David Brooks
| Brain inflammation accompanies amyloid in a majority of mild cognitive impairment cases due to Alzheimer’s disease | 2017 |
|
Professor Nicola Pavese
| Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers | 2017 |
|
Professor Nicola Pavese
Professor David Brooks
| Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients | 2017 |
|
Professor David Brooks
Professor Nicola Pavese
| Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease | 2016 |
|
Dr Dag Aarsland
Professor David Burn
Professor Nicola Pavese
| Cognitive Performance and Neuropsychiatric Symptoms in Early, Untreated Parkinson's Disease | 2015 |
|
Professor Nicola Pavese
Dr Brian Saxby
| Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation | 2012 |
|
